MARKET

TGRP

TGRP

Tron Group
OTCID
0.080
+0.035
+77.78%
Closed 14:11 01/16 EST
OPEN
0.050
PREV CLOSE
0.045
HIGH
0.100
LOW
0.050
VOLUME
120.78K
TURNOVER
9.53K
52 WEEK HIGH
0.100
52 WEEK LOW
0.020
MARKET CAP
14.72M
P/E (TTM)
-23.5294
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TGRP last week (0112-0116)?
Weekly Report · 6h ago
Weekly Report: what happened at TGRP last week (0105-0109)?
Weekly Report · 01/12 10:13
Weekly Report: what happened at TGRP last week (1229-0102)?
Weekly Report · 01/05 10:08
Weekly Report: what happened at TGRP last week (1222-1226)?
Weekly Report · 12/29/2025 10:08
Weekly Report: what happened at TGRP last week (1215-1219)?
Weekly Report · 12/22/2025 10:07
Weekly Report: what happened at TGRP last week (1208-1212)?
Weekly Report · 12/15/2025 10:14
Weekly Report: what happened at TGRP last week (1201-1205)?
Weekly Report · 12/08/2025 10:12
Weekly Report: what happened at TGRP last week (1124-1128)?
Weekly Report · 12/01/2025 10:08
More
About TGRP
TRON Group Inc., formerly Tron Pharmaceuticals, Inc., is a clinical-stage specialty pharmaceutical company. The Company, through its subsidiaries, is developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. It is developing a clinical pipeline of oral, topical and injectable small molecule drug candidates to treat human cancer, central nervous system (CNS) disorders and infectious diseases. Its pipeline includes nine clinical-stage proprietary and partnered programs, including Triapine, Ammonium Tetrathiomolybdate and Aza-TdC, targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3, targeting CNS; PRX-3140 targeting diabetes; and Ramoplanin and NanoDOX, targeting infectious disease. Leveraging its expertise in nanoparticle and fine-particle formulations, the Company is focused on formulation development aimed at improving drug absorption and stability.

Webull offers TRON Group Inc stock information, including OTCID: TGRP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TGRP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TGRP stock methods without spending real money on the virtual paper trading platform.